Pro AAV Manufacturing
Clinical GMP AAV Manufacturing
Adeno-associated virus (AAV) was first found in 1965 in the lab. Recent years, with the development of the technology and research, AAV vector becomes the popular delivery platform for gene therapy. GenScript ProBio, using its proprietary suspension cell line PowerS™-293, with triple transient transfection system, provides a robust and high-quality AAV vector manufacturing platform. The platform is suitable for serotypes including AAV2/5/8/9 and other engineering AAV. Though the high-standard quality control, GenScript ProBio is able to serve customers in different development stages including preclinical, clinical and IND filing, etc.
Packaging Cell Line（Proprietary AAV Cell Line PowerS™-293)
Triple Transient Transfection System Process